Product Information
- (3S,4aR,6R,8aR)-Decahydro-6-[2-(2H-tetrazol-5-yl)ethyl]-3-isoquinolinecarboxylic acid
- 3-Isoquinolinecarboxylic acid, decahydro-6-(2-(1H-tetrazol-5-yl)ethyl)-, (3S,4aR,6R,8aR)-
- 3-Isoquinolinecarboxylic acid, decahydro-6-(2-(1H-tetrazol-5-yl)ethyl)-, (3S-(3alpha,4aalpha,6beta,8aalpha))-
- 3-Isoquinolinecarboxylic acid, decahydro-6-[2-(1H-tetrazol-5-yl)ethyl]-, [3S-(3α,4aα,6β,8aα)]-
- 3-Isoquinolinecarboxylic acid, decahydro-6-[2-(2H-tetrazol-5-yl)ethyl]-, (3S,4aR,6R,8aR)-
- 6-(2-(1H-Tetrazol-5-yl)ethyl)-1,2,3,4,4a,5,6,7,8,8a-decahydroisoquinoline-3-carboxylic acid
- Decahydro-6-(2-(1H-tetrazol-5-yl)ethyl)-3-isoquinolinecarboxylic acid
- Ly 293558
- Ngx 424
- TED-isoquinoline-3-COOH
- See more synonyms
- Tezampanel (anhydrous)
- Unii-Ga36S2O9C2
Tezampanel is a prodrug that is converted to casopitant mesylate after oral administration. Casopitant mesylate is an experimental drug that acts as a selective antagonist at the NK1 receptor, which is involved in mediating pain and inflammation. Tezampanel has been shown to have antinociceptive properties in animal studies. It also reversibly inhibits the activity of glutamate receptors, including NMDA receptors, which are involved in the development of migraine headaches. Clinical studies have demonstrated that tezampanel may be effective for the treatment of migraine headaches.
Chemical properties
Technical inquiry about: 3D-EGA65283 Tezampanel
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
